BioSpace News Archive

PPD, Inc. has been recognized for excellence in the CRO Leadership Awards for the 10th consecutive year, earning praise for its clinical research capabilities and customer compatibility in a survey of pharmaceutical and biotech professionals conducted for Clinical Leader and Life Science Leader magazines.

AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced that Phase 1 testing data will be presented at the 2021 ASCO Annual Meeting June 4, 2021.

PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (CSE: PHRM) (OTCQB: PHRRF), a psychedelics biotech company, is pleased to announce the appointment of Professor Matthew Macaluso, D.O. as a scientific and clinical advisor for PharmaTher’s clinical research programs involving ketamine as a potential treatment for major depressive disorders and amyotrophic lateral sclerosis (“ALS” or “Lou Gehrig’s Disease”).

Tenaya Therapeutics, a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) for TN-201, its most advanced product candidate from its proprietary Gene Therapy Platform.

LARVOL, the leading provider of data and intelligence solutions for the oncology, pharmaceutical, and biotech industries, announced a full line-up of activities during the 2021 American Society of Clinical Oncology Virtual Annual Meeting *.

Innoviva to repurchase GSK’s current 32% stake in the company for $392 million

Apollomics Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, announced that Apollomics Shanghai Branch has been officially opened and started its operations at Zhangjiang Hi-Tech Park, Pudong District, Shanghai.

SanMelix Laboratories, Inc. was named winner of a Stevie® Award in Health & Pharmaceuticals - Product, in The 19th Annual American Business Awards® for its line of BEECure™ products.

Saniona, a clinical stage biopharmaceutical company focused on rare diseases, announcedthat it hosted a virtual R&D day event, during which it discussed its ion channel drug discovery engine and proprietary IONBASE™ database.

Ribometrix, Inc., a biotechnology company developing small molecule therapeutics that directly target RNA to treat human diseases, announced that the company was honored to receive the Triangle Business Journal’s 2021 Life Sciences Award for “Best Early-Stage Product Development Company.”